Kyle Bauser
Stock Analyst at Roth Capital
(3.86)
# 630
Out of 5,067 analysts
25
Total ratings
45.45%
Success rate
14.8%
Average return
Main Sectors:
Stocks Rated by Kyle Bauser
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ELMD Electromed | Reiterates: Buy | $35 → $36 | $26.42 | +36.26% | 5 | Nov 13, 2025 | |
| STXS Stereotaxis | Reiterates: Buy | $4 | $2.36 | +69.49% | 2 | Nov 12, 2025 | |
| INFU InfuSystem Holdings | Reiterates: Buy | $13 → $14 | $9.51 | +47.21% | 2 | Nov 5, 2025 | |
| LMAT LeMaitre Vascular | Reinstates: Buy | $108 | $84.28 | +28.14% | 1 | Nov 5, 2025 | |
| SNWV SANUWAVE Health | Maintains: Buy | $54 → $55 | $33.74 | +63.01% | 2 | Aug 22, 2025 | |
| VREX Varex Imaging | Maintains: Buy | $12 → $16 | $11.01 | +45.32% | 3 | Aug 8, 2025 | |
| TCMD Tactile Systems Technology | Maintains: Neutral | $12 → $13 | $25.57 | -49.16% | 2 | Aug 5, 2025 | |
| TECH Bio-Techne | Initiates: Buy | $65 | $63.49 | +2.38% | 1 | Jul 9, 2025 | |
| SPOK Spok Holdings | Initiates: Neutral | $15 | $12.77 | +17.46% | 2 | Sep 26, 2024 | |
| OBIO Orchestra BioMed Holdings | Initiates: Buy | $15 | $4.84 | +209.92% | 1 | Jul 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $17 | $3.87 | +339.28% | 2 | Jul 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | n/a | $221.97 | - | 2 | Jun 22, 2022 |
Electromed
Nov 13, 2025
Reiterates: Buy
Price Target: $35 → $36
Current: $26.42
Upside: +36.26%
Stereotaxis
Nov 12, 2025
Reiterates: Buy
Price Target: $4
Current: $2.36
Upside: +69.49%
InfuSystem Holdings
Nov 5, 2025
Reiterates: Buy
Price Target: $13 → $14
Current: $9.51
Upside: +47.21%
LeMaitre Vascular
Nov 5, 2025
Reinstates: Buy
Price Target: $108
Current: $84.28
Upside: +28.14%
SANUWAVE Health
Aug 22, 2025
Maintains: Buy
Price Target: $54 → $55
Current: $33.74
Upside: +63.01%
Varex Imaging
Aug 8, 2025
Maintains: Buy
Price Target: $12 → $16
Current: $11.01
Upside: +45.32%
Tactile Systems Technology
Aug 5, 2025
Maintains: Neutral
Price Target: $12 → $13
Current: $25.57
Upside: -49.16%
Bio-Techne
Jul 9, 2025
Initiates: Buy
Price Target: $65
Current: $63.49
Upside: +2.38%
Spok Holdings
Sep 26, 2024
Initiates: Neutral
Price Target: $15
Current: $12.77
Upside: +17.46%
Orchestra BioMed Holdings
Jul 25, 2024
Initiates: Buy
Price Target: $15
Current: $4.84
Upside: +209.92%
Jul 19, 2022
Maintains: Buy
Price Target: $14 → $17
Current: $3.87
Upside: +339.28%
Jun 22, 2022
Initiates: Buy
Price Target: n/a
Current: $221.97
Upside: -